(Q48788562)

15 February 2018

reason for preferred rank

title

BOP/VIP - A new platinum-intensive chemotherapy regimen for poor prognosis germ cell tumours (English)

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

5 November 2022

BOP/VIP--a new platinum-intensive chemotherapy regimen for poor prognosis germ cell tumours (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710482

5 November 2022

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

5 November 2022

author name string

C. R. Lewis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710482

5 November 2022

S. D. Fossà

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710482

5 November 2022

G. Mead

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710482

5 November 2022

W. ten Bokkel Huinink

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710482

5 November 2022

M. J. Harding

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710482

5 November 2022

L. Mill

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710482

5 November 2022

J. Paul

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710482

5 November 2022

W. G. Jones

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710482

5 November 2022

C. J. Rodenburg

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710482

5 November 2022

B. Cantwell

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710482

5 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1710482

5 November 2022

publication date

1 March 1991

1 reference

15 February 2018

full work available at URL

http://annonc.oxfordjournals.org/cgi/content/abstract/2/3/203

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710482

https://api.elsevier.com/content/article/PII:S0923753420314253?httpAccept=text/xml

5 November 2022

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

https://api.elsevier.com/content/article/PII:S0923753420314253?httpAccept=text/plain

5 November 2022

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

http://academic.oup.com/annonc/article-pdf/2/3/203/677067/2-3-203.pdf

5 November 2022

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

5 November 2022

1 reference

15 February 2018

volume

2

1 reference

15 February 2018

issue

3

1 reference

15 February 2018

page(s)

203-211

1 reference

15 February 2018

Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer

cites work

1

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up

5 November 2022

2

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

Testicular cancer: the quest continues

5 November 2022

3

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

Prognostic factors for favorable outcome in disseminated germ cell tumors

5 November 2022

6

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

Results of treatment of non seminomatous germ cell tumours; 122 consecutive cases in the West of Scotland, 1981-1985

5 November 2022

7

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.

5 November 2022

8

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

High-dose cisplatin and VP-16 with bleomycin, in the management of advanced metastatic germ cell tumors

5 November 2022

9

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

Current optimum management of anaplastic germ cell tumours of the testis and other sites

5 November 2022

10

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

Chemotherapy for poor risk germ cell tumours. An independent evaluation of the POMB/ACE regime.

5 November 2022

11

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors

5 November 2022

12

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis

5 November 2022

13

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

Vincristine, cisplatin, and bleomycin with surgery in the management of advanced metastatic nonseminomatous testis tumors

5 November 2022

14

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours

5 November 2022

15

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

5 November 2022

16

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

Ifosfamide in refractory male germ cell tumors

5 November 2022

17

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer

5 November 2022

18

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

Disseminated testicular cancer with bulky disease: results of a phase-II study with cisplatin ultra high dose/VP-16/bleomycin

5 November 2022

19

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

Cisplatin, etoposide, bleomycin first-line therapy and early resection of residual tumor in far-advanced germinal testis cancer

5 November 2022

21

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP)

5 November 2022

22

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

Comparison of criteria for assigning germ cell tumor patients to "good risk" and "poor risk" studies

5 November 2022

23

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

Primary mediastinal nonseminomatous germ cell tumors. A modern single institution experience

5 November 2022

26

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057906

5 November 2022

Identifiers

1 reference

15 February 2018

1 reference

15 February 2018